| Symbol | PHVS |
|---|---|
| Name | PHARVARIS N.V. |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | EMMY NOETHERWEG 2, LEIDEN, 2333 BK, Netherlands |
| Telephone | +31 712036410 |
| Fax | — |
| — | |
| Website | https://www.pharvaris.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001830487 |
| Description | Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Additional info from NASDAQ: |
Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
Read moreLesage Anne 🟡 adjusted position in 4.6K shares (2 derivative) of Pharvaris N.V. (PHVS) at $35.12 Transaction Date: Jun 25, 2026 | Filing ID: 288863
Read moreSchikan Johannes Gerardus Christiaan Petrus 🔴 sold 2.4K shares of Pharvaris N.V. (PHVS) at $35.10 Transaction Date: Jun 29, 2026 | Filing ID: 288840
Read moreLu Peng 🟡 adjusted position in 29.7K shares (2 derivative) of Pharvaris N.V. (PHVS) at $35.09 ($1.2M) Transaction Date: Jun 25, 2026 | Filing ID: 288838
Read more📋 Hans H. Schikan (Director) plans to sell 7K shares of Pharvaris N.V. (at $34.01 each, total $234K) Filed: Jun 29, 2026 | ID: 006623
Read more📋 GrayMatters Consulting B.V. (Officer) plans to sell 7K shares of Pharvaris N.V. (at $34.01 each, total $238K) Filed: Jun 29, 2026 | ID: 006615
Read more📋 ANNE SIMONNE J. LESAGE (Officer) plans to sell 8K shares of Pharvaris N.V. (at $34.01 each, total $282K) Filed: Jun 29, 2026 | ID: 006614
Read more📋 PENG LU (Officer) plans to sell 15K shares of Pharvaris N.V. (at $33.30 each, total $490K) Filed: Jun 26, 2026 | ID: 006552
Read more📋 PENG LU (Officer) plans to sell 15K shares of Pharvaris N.V. (at $33.29 each, total $499K) Filed: Jun 25, 2026 | ID: 006503
Read more📋 GrayMatters Consulting B.V. (Officer) plans to sell 2K shares of Pharvaris N.V. (at $33.29 each, total $77K) Filed: Jun 25, 2026 | ID: 006498
Read more